Show simple item record

Editorial: Non-Dopaminergic Systems in Parkinson's Disease

dc.contributor.authorMiguélez Palomo, Cristina
dc.contributor.authorDe Deurwaerdère, Philippe
dc.contributor.authorSgambato, Veronique
dc.date.accessioned2021-03-04T09:34:22Z
dc.date.available2021-03-04T09:34:22Z
dc.date.issued2020-09-11
dc.identifier.citationFrontiers In Pharmacology 11 : (2020) // Article ID 593822es_ES
dc.identifier.issn1663-9812
dc.identifier.urihttp://hdl.handle.net/10810/50466
dc.description.abstractThe dopaminergic system has been the main focus for almost 70 years and dopaminergic-based strategies still remain the best symptomatic medication to improve quality of life of parkinsonian patients.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectL-Dopaes_ES
dc.subjectserotonines_ES
dc.subjectsleepes_ES
dc.subjectnoradrenalinees_ES
dc.subjectGABAes_ES
dc.subjectnon-motor symptomses_ES
dc.subjectorphan receptores_ES
dc.subjectprodromal Parkinson diseasees_ES
dc.titleEditorial: Non-Dopaminergic Systems in Parkinson's Diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fphar.2020.593822/fulles_ES
dc.identifier.doi10.3389/fphar.2020.593822
dc.departamentoesFarmacologíaes_ES
dc.departamentoeuFarmakologiaes_ES


Files in this item

Thumbnail
Name:
license_rdf
Size:
914bytes
Format:
application/rdf+xml
View/Open
Thumbnail
Name:
fphar-11-593822.pdf
Size:
226.0Kb
Format:
PDF
Description:
Artículo principal
View/Open

This item appears in the following Collection(s)

Show simple item record

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)